Related Experiment Video
Updated: Dec 9, 2025

Dynamic Monitoring of Seroconversion using a Multianalyte Immunobead Assay for Covid-19
Published on: February 16, 2022
New and developing diagnostic platforms for COVID-19: A systematic review
Nidhi Chauhan1, Shringika Soni1, Abhinandan Gupta1
1Amity Institute of Nanotechnology (AINT), Amity University Uttar Pradesh (AUUP) , Noida, 201313, INDIA.
This review examines current diagnostic methods for COVID-19, including RT-PCR and CT scans. Emerging technologies and in-vitro diagnostic kits show promise, but require further research and funding for clinical trials.
Area of Science:
- * Medical Diagnostics
- * Virology
- * Radiology
Background:
- * The emergence of Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2) in late 2019 led to a global pandemic.
- * Coronavirus Disease 2019 (COVID-19) rapidly spread worldwide, causing millions of infections and thousands of deaths.
- * Current diagnostic standards include reverse transcription-polymerase chain reaction (RT-PCR) and computed tomography (CT) scanning.
Purpose of the Study:
- * To systematically review current diagnostic methods for COVID-19 detection.
- * To explore the future prospects of emerging diagnostic technologies for SARS-CoV-2.
- * To discuss the status of commercially available diagnostic kits.
Main Methods:
- * Conducted online literature searches on Google Scholar, PubMed, and other online resources.
- * Included studies published between 2017 and mid-2020.
- * Focused on laboratory examinations, radiographical analysis, and potential sensors for COVID-19 detection.
Main Results:
- * Identified potential applications of nucleic acid technology, diagnostic radiology, and in-vitro diagnostic kits for COVID-19 detection.
- * Summarized emerging diagnostic technologies currently undergoing clinical trials.
- * Acknowledged limitations associated with each diagnostic technology.
Conclusions:
- * Nucleic acid technology, radiology, and in-vitro kits are key for COVID-19 detection.
- * Further collaboration and funding are essential to accelerate clinical trials for new diagnostic tools.
- * Continued development is needed to overcome limitations of current and emerging diagnostic methods.
Related Concept Videos
Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care
Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies
Medical History
Acute Coronary Syndrome III: Diagnostic Studies

